Should Investors Give Intel Stock Another Look After Its AI Strategy Reset?

Since Lip-Bu Tan became CEO in March, Intel has flattened management and refocused on AI inference, securing $8.9B in U.S. government support, $2B from SoftBank and a $5B investment/partnership from Nvidia to build custom AI data-center and PC products. Financially, H1 2025 revenue was $25.5B (essentially flat YoY) with a YTD net loss attributable to Intel of $3.7B (vs. prior-year $2.0B loss), but Q3 revenue rose 3% YoY to $13.7B and Intel reported net income attributable to the company of $4.1B versus a $16.6B loss in the prior-year quarter. Shares have rallied from a 52-week low of $17.67 to $44.02, driving a sharp expansion in the trailing P/E—leaving valuation elevated relative to peers (TSMC P/E ~30) and prompting a recommendation to wait for a price pullback despite improved fundamentals.

Analysis

Market structure: Intel, Nvidia (NVDA) and hyperscalers/AI software winners if Intel converts government grants ($8.9B), SoftBank $2B and Nvidia’s $5B into usable fab & inference SKUs; Apple (AAPL) benefits from supplier diversification. Pure-play foundries (TSM) face competitive pressure on certain AI inference workloads, but TSM retains pricing power for advanced nodes. Short-term supply tightness for inference-optimized chips should keep OEM leverage, raising capex intensity across equipment vendors and modestly tightening semiconductor-sector credit spreads.

Risk assessment: Key tail risks are execution (fab delays, yield misses), geopolitical export controls, and partnership fallout (NVDA or Apple scaling back), any of which could erase re-rating; financial risk includes equity dilution if further capital needed. Immediate horizon (days-weeks): elevated volatility and potential profit-taking; short-term (3–12 months): revenue proof points (Apple ramp, AI product launches) required to justify P/E expansion; long-term (2–5 years): market for inference chips could grow >20% CAGR but capture is uncertain. Hidden dependency: Intel’s progress is highly levered to third-party IP, Nvidia cooperation, and EUV supply.

Trade implications: Avoid buying momentum at current valuation spikes. Tactical: harvest gains and await confirmatory revenue growth — target re-entry when INTC falls to <$35 or TTM P/E <20, or on sustained quarterly revenue growth >15% YoY. Use pair trades (long TSM or NVDA, short INTC) to express relative-quality, and use 1–3 month put spreads to hedge downside risk while selling premium on elevated IV.

Contrarian angles: Consensus underestimates that AI value likely accrues to software/accelerator ecosystems, not fabs; Intel’s cultural and execution drag is persistent despite management change. The market may be overpricing a quick turnaround: historical parallels (IBM/Intel prior cycles) show multi-year recoveries. Unintended consequence: large external investments (NVDA, gov’t) could limit Intel’s strategic optionality or trigger dilution if milestones slip.

Key Decisions for Investors

• Trim INTC exposure to 1–2% of portfolio if current weight >3%; take profits now and plan re-entry only if INTC < $35 or trailing P/E falls below 20, or after two consecutive quarters of >15% YoY revenue growth (target 6–12 months).
• Establish a relative-value pair: long TSM (2% notional) funded by short INTC (1–2% notional) with 6–12 month horizon; target TSM outperformance of +15% and place stop-loss if the spread moves against by 8%.
• Buy protection on INTC via a 3-month put spread sized to position: buy 10% OTM put and sell 20% OTM put (cost-limited hedge) to protect against >10% downside; roll/assess at 3 months based on Apple/quarterly execution news.
• Add selective exposure to NVDA or TSM (1–2% each) on 5–10% pullbacks over next 3 months to capture pure-play AI/foundry growth; cap total incremental AI-related exposure to <6% of portfolio to limit concentration risk.